Effects of hydrogen sulfide on renal fibrosis in diabetic rats and its mechanism

doi:10.12047/j.cjap.5734.2018.128

Abstract

Abstract: Objective: To investigate the effects of hydrogen sulfide (H₂S) on renal fibrosis in diabetic rats and explore its mechanism.Methods: Male Sprague-Dawley rats were randomly divided into normal control (NC) group, a diabetic control (DC) group, diabetes mellitus (DM)+sodium hydrosulfide (NaHS) group and DM+DL-propargylglycine (PAG) group, with 8 rats in each group.Type 1 diabetes was induced in the respective groups by a single intraperitoneal (i.p.) injection of streptozotocin.From the fifth week, rats in the DM+NaHS and DM+PAG groups were injected (i.p.) with 56 μmol/kg NaHS and 40 mg/kg PAG once a day, respectively.After treatment for 4 weeks, the levels of fasting blood glucose (FBG), blood urea nitrogen (BUN) and serum creatinine (SCr) were detected.The deposition of renal collagen fibers was observed by Masson staining, and collagen volume fraction (CVF) was calculated.The ultrastructural change of renal tissue was observed by transmission electron microscopy.The levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and hydroxyproline (Hyp) in renal tissues were detected using the kits.The expression levels of TGF-β1, Smad3, phosphorylated (p)-Smad3 and collagen-IV (col-IV) in renal tissues were detected using Western blot.Results: Compared with the NC group, the levels of FBG, BUN, SCr, CVF, IL-1β, IL-6, TNF-α and Hyp were increased; the deposition of renal collagen fibers and the ultrastructural damage were aggravated; the levels of TGF-β1, Smad3, p-Smad3, p-Smad3/Smad3 and col-IV were increased in the DC group.Compared with the DC group, excluding FBG, the aforementioned indices were improved in the DM+NaHS group; the aforementioned indices were further aggravated in the DM+PAG group.Conclusion: H₂S attenuated renal fibrosis in diabetic rats, and the mechanism might be associated with the reduction of the release of proinflammatory cytokines, downregulation of the TGF-β1/Smad3 pathway, and inhibition of excessive accumulation of col-IV.

Key words: hydrogen sulfide, diabetes mellitus, kidney, fibrosis, transforming growth factor-β1/Smad3 pathway, rat

JIA Qiang, WANG Lei, WANG Qi-yi, LIU Xiao-fen, MA Shan-feng, YANG Rui. Effects of hydrogen sulfide on renal fibrosis in diabetic rats and its mechanism[J]. CJAP, 2018, 34(6): 572-576.

References

[1] 杨锐, 刘小粉, 马善峰, 等. 硫化氢对1型糖尿病大鼠肾脏的保护作用[J]. 中国应用生理学杂志, 2016, 32(2):84-87.
[2] LeBleu VS, Taduri G, O'Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis[J]. Nat Med, 2013, 19(8):1047-1053.
[3] Morishita Y, Imai T, Yoshizawa H, et al. Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo[J]. Int J Nanomedicine, 2015, 10:3475-3488.
[4] Meng XM, Tang PM, Li J, et al. TGF-β/Smad signaling in renal fibrosis[J]. Front Physiol, 2015, 6:82.
[5] Beltowski J. Hydrogen sulfide in pharmacology and medicine——An update[J]. Pharmacol Rep, 2015, 67(3):647-658.
[6] Yang R, Jia Q, Liu XF, et al. Effects of hydrogen sulfide on inducible nitric oxide synthase activity and expression of cardiomyocytes in diabetic rats[J]. Mol Med Rep, 2017, 16(4):5277-5284.
[7] Zhang X, Bian JS. Hydrogen sulfide:a neuromodulator and neuroprotectant in the central nervous system[J]. ACS Chem Neurosci, 2014, 5(10):876-883.
[8] di Masi A, Ascenzi P. H₂S:a "double face" molecule in health and disease[J]. Biofactors, 2013, 39(2):186-196.
[9] Du J, Jin H, Yang L. Role of hydrogen sulfide in retinal diseases[J]. Front Pharmacol, 2017, 8:588.
[10] Han SJ, Noh MR, Jung JM, et al. Hydrogen sulfide-producing cystathionine γ-lyase is critical in the progression of kidney fibrosis[J]. Free Radic Biol Med, 2017, 112:423-432.
[11] 马继伟, 王宏天, 刘浩飞, 等. 积雪草对转染TGF-β1基因的大鼠肾小球系膜细胞Smad 2/3、Smad 7和胶原蛋白Ⅳ表达的影响[J]. 中国应用生理学杂志, 2018, 34(2):122-125.
[12] Diez-Marques L, Ortega-Velazquez R, Langa C, et al. Expression of endoglin in human mesangial cells:modulation of extracellular matrix synthesis[J]. Biochim Biophys Acta, 2002, 1587(1):36-44.
[13] 杨锐, 贾强, 马善峰, 等. 硫化氢对1型糖尿病大鼠膈肌NO含量和iNOS活性的影响[J]. 中国应用生理学杂志, 2017, 33(3):248-251.
[14] Li L, Xiao T, Li F, et al. Hydrogen sulfide reduced renal tissue fibrosis by regulating autophagy in diabetic rats[J]. Mol Med Rep, 2017, 16(2):1715-1722.
[15] 黄成亮, 李艳艳, 范贤明, 等. 丹参联合川芎嗪对肺纤维化大鼠血清、支气管肺泡灌洗液中TNF-α和TGF-β1水平的影响[J]. 细胞与分子免疫学杂志,2013, 29(7):673-676.
[16] Sutariya B, Saraf M. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway[J]. J Ethnopharmacol, 2017, 198:432-443.
[17] Samarakoon R, Overstreet JM, Higgins SP, et al. TGF-β1→SMAD/p53/USF2→PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis[J]. Cell Tissue Res, 2012, 347(1):117-128.
[18] Wu CF, Chiang WC, Lai CF, et al. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis[J]. Am J Pathol, 2013, 182(1):118-131.
[19] Hata A, Chen YG. TGF-β signaling from receptors to Smads[J]. Cold Spring Harb Perspect Biol, 2016, 8(9):a022061.
[20] Fan K, Wu K, Lin L, et al. Metformin mitigates carbon tetrachloride-induced TGF-β1/Smad3 signaling and liver fibrosis in mice[J]. Biomed Pharmacother, 2017, 90:421-426.
[21] Li X, Han D, Tian Z, et al. Activation of cannabinoid receptor type Ⅱ by AM1241 ameliorates myocardial fibrosis via Nrf2-mediated inhibition of TGF-β1/Smad3 pathway in myocardial infarction mice[J]. Cell Physiol Biochem, 2016, 39(4):1521-1536.
[22] Qu Y, Zhang L, Kang Z, et al. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway[J]. Pulm Pharmacol Ther, 2015, 34:1-7.